I.  Review how impaired renal function affects anticoagulant metabolism.

2.Identify appropriate anticoagulants based on CKD severity

3. Evaluate thrombotic and bleeding risks in CKD/ESRD.

4. Summarize key guidelines and trial data.

Session date: 
02/14/2025 - 8:00am to 9:00am CST
Add to calendar: 
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation

Please login or create an account to proceed.
Speaker Name: 
Jyoti Brar, MD